title: [Current therapeutic agents: dornase alfa].
abstract: The authors present dornase alfa, a new drug for the long-term treatment of patients with cystic fibrosis: clinical interest, practical and economic aspects.
authors.affiliation: Service de Pneumologie Pédiatrique, Hôpital Erasme, Bruxelles.
authors.forename: D
authors.initials: D
authors.lastname: Baran
authors.forename: J
authors.initials: J
authors.lastname: Sternon
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D002648:Child; D002675:Child, Preschool; D003550:Cystic Fibrosis / Q000188:drug therapy* / Q000503:physiopathology; D003850:Deoxyribonuclease I / Q000627:therapeutic use*; D005100:Expectorants / Q000627:therapeutic use*; D006801:Humans; D008176:Lung Volume Measurements; D008875:Middle Aged; D011994:Recombinant Proteins / Q000627:therapeutic use
chemical_list: D005100:Expectorants; D011994:Recombinant Proteins; C085693:DNASE1 protein, human; D003850:Deoxyribonuclease I